Glucotrack (GCTK) Non-Current Assets (2010 - 2025)
Glucotrack's (GCTK) quarterly Non-Current Assets came in at $171000.0 in Q4 2025, up 4.27% YoY from $164000.0 in Q4 2024, and down 7.07% on a QoQ basis from $184000.0 in Q3 2025.
Glucotrack (GCTK) Non-Current Assets (2010 - 2025) Analysis & Trends
Glucotrack (GCTK) has 16 years of Non-Current Assets data on file, last reported at $171000.0 in Q4 2025.
- Quarterly Non-Current Assets rose 4.27% year-over-year to $171000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $645000.0 (down 5.56% YoY) and the FY2025 annual result came in at $171000.0, up 4.27% from the prior year.
- Non-Current Assets eased to $171000.0 in Q4 2025, from $184000.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $348000.0 in Q1 2021 to a low of $26000.0 in Q3 2023.
- A 5-year average of $142650.0 and a median of $158500.0 in 2021 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets tumbled 68.67% — and 2024, when it soared 607.69%.
- Tracing GCTK's Non-Current Assets over 5 years: stood at $160000.0 in 2021, then tumbled by 63.12% to $59000.0 in 2022, then plunged by 37.29% to $37000.0 in 2023, then jumped by 343.24% to $164000.0 in 2024, then increased by 4.27% to $171000.0 in 2025.
- The last three Non-Current Assets figures came in at $171000.0 (Q4 2025), $184000.0 (Q3 2025), and $133000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Glucotrack | 1.73 Mn | 607,139.82 | - | 114,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 171,000.00 |
| Sep 30, 2025 | 184,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 157,000.00 |
| Dec 31, 2024 | 164,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 166,000.00 |
| Mar 31, 2024 | 169,000.00 |
| Dec 31, 2023 | 37,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 37,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Dec 31, 2022 | 59,000.00 |
| Sep 30, 2022 | 83,000.00 |
| Jun 30, 2022 | 93,000.00 |
| Mar 31, 2022 | 128,000.00 |
| Dec 31, 2021 | 160,000.00 |
| Sep 30, 2021 | 214,000.00 |
| Jun 30, 2021 | 295,000.00 |
| Mar 31, 2021 | 348,000.00 |